Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Opioid Prescription After Cesarean Trial

ClinicalTrials.gov ID: NCT04296396

Public ClinicalTrials.gov record NCT04296396. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prescription After Cesarean Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Non-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that includes shared decision making or to a fixed opioid prescription of 20 tablets of oxycodone 5mg.

Study identification

NCT ID
NCT04296396
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
5,521 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2020 (Actual)
Primary completion
Apr 7, 2022 (Actual)
Completion
Jul 8, 2022 (Actual)
Last update posted
Oct 3, 2023

2020 – 2022

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35233 —
Northwestern University Chicago Illinois 60611 —
Columbia University New York New York 10032 —
University of North Carolina-Chapel Hill Chapel Hill North Carolina 17599 —
Case Western Reserve-Metrohealth Cleveland Ohio 44109 —
Ohio State University Columbus Ohio 43210 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Magee Womens Hospital of UPMC Pittsburgh Pennsylvania 15213 —
Brown Univeristy Providence Rhode Island 02905 —
University of Texas Medical Branch Galveston Texas 77555 —
University of Texas - Houston Houston Texas 77030 —
University of Utah Medical Center Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04296396, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 3, 2023 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04296396 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →